Of the lesions, 72 (35.8%) were malignant. Remote-CCM had a sensitivity for malignancy detection of 0.89 (95% CI, 0.79-0.95), and the specificity was 0.64 (95% CI, 0.55-0.73), with minimal differences ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
As previously announced, IMUNON plans to hold an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in person to discuss the design for a Phase 3 pivotal study of IMNN-001 in ...
“RYTELO is an important therapy for the lower-risk MDS patient population, who otherwise have limited treatment options, and we look forward to its development in other hematologic malignancy ...